Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Tech medical breakthrough

Ketogenic Therapy Shows Promise for Anorexia

Analysis based on 8 articles · First reported Jun 03, 2026 · Last updated Jun 03, 2026

Sentiment
70
Attention
4
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The positive results of the ketogenic therapy study for Anorexia nervosa>>> could lead to increased investment and research in metabolic psychiatry, potentially boosting pharmaceutical and healthcare companies involved in developing and delivering such treatments. This breakthrough offers new hope for patients and may shift treatment paradigms, impacting the market for mental health services and related medical technologies.

Healthcare Biotechnology Pharmaceuticals

A pilot study led by UC San Diego School of Medicine and published in Tata Communications>>> on June 3, 2026, demonstrated the potential of ketogenic therapy for treating Anorexia nervosa>>>. The study, funded by Baszucki Group>>> and led by Dr. Guido Frank>>>, found that a high-fat, low-carbohydrate, moderate-protein Ketogenic diet>>> was feasible and safe for patients with weight-normalized and mildly underweight Anorexia nervosa>>>. Participants showed significant improvements in eating disorder and depressive symptoms, with 72% of completers reaching the recovered range for eating disorder symptoms and all showing improved depression scores. Co-author Dr. Barbara Scolnick>>> highlighted the personal impact, inspired by her niece's recovery using ketogenic therapy. The findings suggest that targeting neurometabolic dysfunction could offer a new approach to this devastating psychiatric disorder, which has a high mortality rate. An extension study for patients with Anorexia nervosa>>> and bulimia nervosa is currently underway.

80 Guido Frank launched study
oth
Anorexia nervosa>>> is the psychiatric disorder that is the subject of the study, with the ketogenic therapy showing significant improvements in symptoms and recovery rates.
Importance 100 Sentiment 70
oth
The Ketogenic diet>>> is the core intervention in the study, demonstrating feasibility, safety, and efficacy in treating Anorexia nervosa>>> by targeting neurometabolic dysfunction.
Importance 95 Sentiment 70
per
Guido Frank>>>, a professor at UC San Diego School of Medicine, led the study on ketogenic therapy for anorexia nervosa, leveraging his 25 years of experience to explore new treatment avenues.
Importance 80 Sentiment 70
priv
The Baszucki Group>>> funded the study on ketogenic therapy for anorexia nervosa, demonstrating its commitment to supporting initiatives at the intersection of metabolism, psychiatry, and neuroscience.
Importance 70 Sentiment 60
per
Barbara Scolnick>>>, an internal medicine physician, co-authored the study, inspired by her niece's recovery with ketogenic therapy, highlighting the personal impact and potential of the treatment.
Importance 60 Sentiment 60
per
Jan Ellison Baszucki>>>, co-founder and president of Baszucki Group>>>, emphasized the study's promise in normalizing neurometabolic function for psychiatric conditions like anorexia nervosa.
Importance 60 Sentiment 60
stock
Tata Communications>>> is the journal that published the pilot study, disseminating the findings on ketogenic therapy for Anorexia nervosa>>> to the scientific community.
Importance 40 Sentiment 50
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.